The purpose of this study is to compare how well the VivAer procedure, septoplasty and functional rhinoplasty work in the parts of the nose that cause nasal airway obstruction and to determine how symptoms respond after treatment. The study focuses on patients with nasal airway obstruction whose doctor has recommended that they receive the VivAer procedure as treatment. Nasal airway obstruction is a condition in which something blocks the airflow into the nose, making it hard to breathe. This study will help researchers understand how well the VivAer device works compared to other treatment options. Participants at Cedars-Sinai will receive the VivAer Stylus, which is a device that will be used on the areas in the nose that have been determined to cause the patient’s nasal obstruction symptoms. This treatment is part of usual care for the treatment of nasal obstruction. Study procedures include collection of data from medical records, physical exams, and questionnaires. The U.S. Food and Drug Administration (FDA) has approved the devices used during the VivAer procedure.